A VNS, or vagus nerve stimulator, is a small device implanted in the chest that sends mild electrical pulses to the brain through the vagus nerve. It works similarly to a pacemaker, but instead of regulating heartbeats, it modulates brain activity to reduce seizures, treat depression, and aid stroke recovery. The FDA first approved VNS for epilepsy, and it remains the most common reason people get one.
How the Device Works
The vagus nerve is one of the longest nerves in your body, running from your brainstem down through your neck and into your chest and abdomen. It carries signals in both directions, relaying information between your brain and your organs. A VNS device takes advantage of this highway by sending electrical impulses up through the nerve to brain regions that control seizures, mood, and inflammation.
Once those signals reach the brainstem, they trigger a cascade of chemical changes. The brain increases production of key signaling chemicals that have natural anti-seizure effects and play a role in mood regulation. In epilepsy, the stimulation appears to break up the abnormal synchronized electrical activity that causes seizures. In depression, the same pathways improve signaling in brain circuits tied to mood. The vagus nerve also plays a role in controlling inflammation throughout the body, which is why researchers are exploring VNS for a growing list of conditions.
What Gets Implanted and Where
The surgery involves two small incisions. The first is a 2 to 3 centimeter cut on the left side of the neck, where the surgeon wraps a thin wire electrode around the left vagus nerve. The second incision, roughly the same size, is made about 5 centimeters below the collarbone, where a small pulse generator (about the size of a silver dollar) is placed under the skin. The wire runs under the skin between the two sites, connecting the electrode to the generator.
Only the left vagus nerve is used. The FDA specifically requires stimulation below the point where cardiac nerve branches split off, which minimizes any effect on heart rhythm. The procedure is typically done under general anesthesia and is considered outpatient surgery for many patients.
The generator runs on a battery that will eventually need replacing. In a long-term study, 27% of patients needed a generator replacement due to battery depletion, and about 46% required at least one replacement or revision surgery over the life of their device. Replacing the generator is a simpler procedure than the original implant since the electrode stays in place.
Approved Uses: Epilepsy
VNS is FDA-approved as an add-on therapy for people aged 4 and older with partial onset seizures that don’t respond adequately to medication. It’s not a replacement for anti-seizure drugs. Instead, it works alongside them to bring seizure frequency down further.
A large meta-analysis covering more than 2,600 patients with drug-resistant epilepsy found that 46% experienced at least a 50% reduction in seizure frequency with VNS. That’s a meaningful improvement for people whose seizures hadn’t responded to multiple medications. The device delivers stimulation on a preset schedule, typically cycling on for 30 seconds and off for several minutes, around the clock.
Patients also receive a handheld magnet they can swipe over the generator to trigger an extra burst of stimulation when they feel a seizure coming on. About 45% of magnet users report some benefit, and roughly 28% report that magnet-triggered stimulation actually stops a seizure. Others notice shorter or less intense episodes. The magnet isn’t always practical, though. Many people are unaware of their seizures before they happen, are asleep, or simply don’t have the magnet within reach.
Approved Uses: Depression
VNS is also approved for treatment-resistant depression in adults who haven’t improved after trying at least four other treatments. Unlike its effects in epilepsy, which can appear relatively quickly, the antidepressant benefits of VNS tend to build gradually over months or even years.
Long-term studies show response rates between 28% and 57% in larger patient groups, with remission rates (meaning symptoms largely resolve) ranging from 19% to 39%. Those numbers may sound modest, but these are patients for whom standard antidepressants, therapy, and other interventions have already failed. For a condition that’s otherwise difficult to treat, a meaningful response in roughly one-third to one-half of patients represents a real option.
Stroke Rehabilitation
One of the newer applications for VNS is helping stroke survivors regain arm and hand function. In this approach, the device delivers a pulse at the exact moment a patient performs a rehabilitation exercise, which appears to strengthen the brain’s ability to rewire itself around the damaged area.
In the VNS-REHAB trial, almost half of participants in the VNS group achieved clinically meaningful improvements in upper limb function, roughly twice the rate of those doing physical therapy alone. Other studies have reported gains of 14 to 17 points on a standard arm function scale, which can translate to meaningful real-world abilities like gripping objects or reaching overhead. The FDA approved VNS for chronic ischemic stroke rehabilitation in 2021.
Common Side Effects
Most side effects from VNS are tied to the stimulation itself, not the surgery. The most frequently reported include voice changes or hoarseness, throat pain, cough, headaches, shortness of breath, and a tingling sensation on the skin. These tend to occur during the “on” periods when the device is actively stimulating and often improve over time as the body adjusts. Some people also experience trouble sleeping or worsening of existing sleep apnea.
Surgical complications are uncommon and similar to risks with any minor surgery: pain at the incision site, infection, and in rare cases, temporary vocal cord weakness. For most people, side effects become manageable or fade within the first few months, though some persist for as long as the device is in use.
Non-Invasive Alternatives
Not every form of vagus nerve stimulation requires surgery. Transcutaneous VNS (tVNS) delivers electrical stimulation through the skin, either at the ear or on the neck, without any implant. Ear-based devices target a small patch of skin in the outer ear where vagus nerve fibers surface. Neck-based devices press against the skin over the muscle that runs along the side of the neck.
These non-invasive options avoid surgical risks entirely and eliminate the chance of directly affecting heart-regulating nerve fibers. The tradeoff is precision. The vagus nerve sits roughly 10 to 15 millimeters below the skin’s surface in the neck, buried beneath muscle and tissue, which makes it difficult for surface electrodes to selectively target the right nerve fibers. Non-invasive devices likely stimulate a mix of nerve fibers going in both directions, which may reduce their effectiveness compared to the implanted version. Research on tVNS is active but still evolving for most conditions.
What Daily Life Looks Like With a VNS
Once implanted and programmed, the device runs automatically. You’ll visit your neurologist or psychiatrist periodically to adjust the stimulation settings, which can be fine-tuned for pulse strength, duration, and frequency. Many people notice a slight change in their voice or a tickle in the throat when the device cycles on, but this becomes routine quickly.
The generator creates a small visible bump under the skin below the collarbone. MRI scans require special protocols, and strong magnets in the environment can inadvertently trigger or pause the device. Beyond those considerations, most people return to normal activities without significant lifestyle changes. The device doesn’t cure the underlying condition, but for many patients with epilepsy, depression, or stroke-related disability, it provides a level of improvement that medications alone couldn’t achieve.